Cite

Armstrong R, Sridhar M, Greenhalgh KL, Howell L, Jones C, Landes C, McPartland JL, Moores C, Losty PD, Didi M. Phaeochromocytoma in children. Arch Dis Childhood 93, 899–904, 2008. Search in Google Scholar

Barontini M, Levin G, Sanso G. Characteristics of pheochromocytoma in a 4- to 20-year-old population. Ann NY Acad Sci 1073, 30–37, 2006. Search in Google Scholar

Bausch B, Wellner U, Bausch D. Schiavi F, Barontini M, Sanso G, et al. Long-term prognosis of patients with pediatric pheochromocytoma. Endocr Relat Cancer 21, 17–25, 2014. Search in Google Scholar

Bouloux PM, Fakehh M. Pheochromocytoma. In: Sheaves R, Jenkins PJ, Wass JA, editors. Clinical endocrine oncology, Oxford Cambridge (Mass), Blackwell Science, 299–305, 1997. Search in Google Scholar

Brouwers FM, Eisenhofer G, Tao JJ, Kant JA, Adams KT, Linehan WM, Pacak K. High frequency of SDHB germline mutations in patients with malignant catecholamine-producing paragangliomas: implications for genetic testing. J Clin Endocrinol Metab 91, 4505–4509, 2006. Search in Google Scholar

Caty MG, Coran AG, Geagen M, Thompson NW. Current diagnosis and treatment of pheochromocytoma in children. Experience with 22 consecutive tumors in 14 patients. Arch Surg 125, 978–981, 1990. Search in Google Scholar

Chen H, Sippel RS, O’Dorisio MS, Vinik AI, Lloyd RV, Pacak K; North American Neuroendocrine Tumor Society (NANETS). The North American Neuroendocrine Tumor Society consensus guideline for the diagnosis and management of neuroendocrine tumors: pheochromocytoma, paraganglioma, and medullary thyroid cancer. Pancreas 39, 775–783, 2010. Search in Google Scholar

Choat H, Derrevere K, Knight L, Brown W, Mack EH. SDHB-associated paraganglioma in a pediatric patient and literature review on hereditary pheochromocytoma-paraganglioma syndromes. Case Rep Endocrinol 502734, 2014. Search in Google Scholar

Ciftci AO, Tanyel FC, Senocak ME, Buyukpamukcu N. Pheochromocytoma in children. J Pediatr Surg 36, 447–452, 2001. Search in Google Scholar

Crago RM, Eckholdt JW, Wismell JG. Pheochromocytoma. Treatment with alpha- and beta-adrenergic blocking drugs. JAMA 202, 870–874, 1967. Search in Google Scholar

Entrez Gene: succinate dehydrogenase complex. Search in Google Scholar

Gottlieb E, Tomlinson IP. Mitochondrial tumour suppressors: a genetic and biochemical update. Nat Rev Cancer 5, 857–866, 2005. Search in Google Scholar

Huang Y, Wang LA, Xie Q, Pang J, Wang L, Yi Y, Zhang J, Zhang Y, Chen R, Lan W, Zhang D, Jiang J. Germline SDHB and SDHD mutations in pheochromocytoma and paraganglioma patients. Endocr Connect 7, 1217–1225, 2018. Search in Google Scholar

Jochmanova I, Wolf KI, King KS, Nambuba J, Wesley R, Martucci V, Raygada M, Adams KT, Prodanov T, Fojo AT, Lazurova I, Pacak K. SDHB-related pheochromocytoma and paraganglioma penetrance and genotypephenotype correlations. J Cancer Res Clin Oncol 143, 1421–1435, 2017. Search in Google Scholar

King KS, Prodanov T, Kantorovich V, Fojo T, Hewitt JK, Zacharin M et al. Metastatic pheochromocytoma/paraganglioma related to primary tumor development in childhood or adolescence: significant link to SDHB mutations. J Clin Oncol 29, 4137–4142, 2011. Search in Google Scholar

King KS, Pacak K. Familial pheochromocytomas and paragangliomas. Mol Cell Endocrinol 386, 1-2, 92–100, 2014. Search in Google Scholar

Klingler HC, Klingler PJ, Martin JK Jr, Smallridge RC, Smith SL, Hinder RA. Pheochromocytoma. Urology 57, 1025–1032, 2001. Search in Google Scholar

Knudson AG Jr. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA 68, 820–823, 1971. Search in Google Scholar

Lenders JW, Pacak K, Walther MM, Linehan WM, Mannelli M, Friberg P, Keiser HR, Goldstein DS, Eisenhofer G. Biochemical diagnosis of pheochromocytoma: which test is best? JAMA 287, 1427–1434, 2002. Search in Google Scholar

Lenders JW, Eisenhofer G, Mannelli M, Pacak K. Phaeochromocytoma. Lancet 366, 665–675, 2005. Search in Google Scholar

Maurea S, Cuocolo A, Reynolds JC, Neumann RD, Salvatore M. Diagnostic imaging in patients with paragangliomas. Computed tomography, magnetic resonance and MIBG scintigraphy comparison. Q J Nucl Med 40, 365–371, 1996. Search in Google Scholar

Neumann HP, Bausch B, McWhinney SR, Bender BU, Gimm O, Franke G, et al. Germ-line mutations in nonsyndromic pheochromocytoma. N Engl J Med 346, 1459–1466, 2002. Search in Google Scholar

Neumann HP, Pawlu C, Peczkowska M, Bausch B, McWhinney SR, Muresan M, Buchta M, Franke G, Klisch J, Bley TA, Hoegerle S, Boedeker CC, Opocher G, Schipper J, Januszewicz A, Eng C; European-American Paraganglioma Study Group. Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations. JAMA 292, 943–951, 2004. Search in Google Scholar

Neumann HP, Young WF, Krauss T, Bayley JP, Schiavi F, Opocher G, et al. 65 years of the double helix: genetics informs precision practice in the diagnosis and management of pheochromocytoma. Endocr Relat Cancer 25, T201–T219, 2018. Search in Google Scholar

Pacak K. Preoperative management of the pheochromocytoma patient. J Clin Endocrinol Metab 92, 4069–4079, 2007. Search in Google Scholar

Pamporaki C, Hamplova B, Peitzsch M, Prejbisz A, Beuschlein F, Timmers HJLM, Fassnacht M, Klink B, Lodish M, Stratakis CA, Huebner A, Fliedner S, Robledo M, Sinnott RO, Januszewicz A, Pacak K, Eisenhofer G. Characteristics of pediatric vs adult pheochromocytomas and paragangliomas. J Clin Endocrinol Metab 102, 1122–1132, 2017. Search in Google Scholar

Pedziwiatr M, Wierdak M, Ostachowski M, Natkaniec M, Bialas M, Hubalewska-Dydejczyk A, Matlok M, Major P, Budzynski P, Migaczewski M, Budzynski A. Single center outcomes of laparoscopic transperitoneal lateral adrenalectomy—lessons learned after 500 cases: a retrospective cohort study. Int J Surg 20, 88–94, 2015. Search in Google Scholar

Plouin PF, Amar L, Dekkers OM, Fassnacht M, Gimenez-Roqueplo AP, Lenders JW, Lussey-Lepoutre C, Steichen O; Guideline Working Group. European Society of Endocrinology Clinical Practice Guideline for long-term follow-up of patients operated on for a phaeochromocytoma or a paraganglioma. Eur J Endocrinol 174, G1–G10, 2016. Search in Google Scholar

Ricketts C, Woodward ER, Killick P, Morris MR, Astuti D, Latif F, Maher ER. Germline SDHB mutations and familial renal cell carcinoma. J Nat Cancer Institute, 100, 1260–1262, 2008. Search in Google Scholar

Romero M, Kapur G, Baracco R, Valentini RP, Mattoo TK, Jain A. Treatment of hypertension in children with catecholamine‐secreting tumors: a systematic approach J Clin Hypertens 17, 720–725, 2015. Search in Google Scholar

Sheps SG, Jiang NS, Klee GG, van Heerden JA. Recent developments in the diagnosis and treatment of pheochromocytoma. Mayo Clin Proc 65, 88–95, 1999. Search in Google Scholar

Shimazui T, Kikuchi K, Sato K, Kiriyama I, Ishikawa S, Nemoto R, Koiso K, Kurosaki Y. Detectability and characteristics of the primary adrenal tumor by ultrasonography--comparison with CAT scan and adrenal scintigraphy. Nippon Hinyokika Gakkai Zasshi 80, 1031–1036, 1989. Search in Google Scholar

Sun F, Huo, X, Zhai Y, Wang A, Xu J, Su D, Bartlam M, Rao Z. Crystal structure of mitochondrial respiratory membrane protein complex II. Cell 121, 1043–1057, 2005. Search in Google Scholar

van der Horst-Schrivers AN, Kerstens MN, Wolffenbuttel BH. Preoperative pharmacological management of phaeochromocytoma. Neth J Med 64, 290–295, 2006. Search in Google Scholar

Wong MY, Andrews KA, Challis BG, Park SM, Acerini CL, Maher ER, Casey RT. Clinical Practice Guidance: surveillance for phaeochromocytoma and paraganglioma in paediatric succinate dehydrogenase gene mutation carriers. Clin Endocrinol (Oxf) 90, 499–505, 2019. Search in Google Scholar

Zong NC, Li H, Li H, Lam MP, Jimenez RC, Kim CS, Deng N, Kim AK, Choi JH, Zelaya I, Liem D, Meyer D, Odeberg J, Fang C, Lu HJ, Xu T, Weiss J, Duan H, Uhlen M, Yates JR 3rd, Apweiler R, Ge J, Hermjakob H, Ping P. Integration of cardiac proteome biology and medicine by a specialized knowledgebase. Circ Res 113, 1043–1053, 2013. Search in Google Scholar

eISSN:
1336-0329
Language:
English